MedPath

DEPUY SPINE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:10

Trial Phases

4 Phases

Phase 1:3
Phase 2:1
Phase 3:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (37.5%)
Phase 3
3 (37.5%)
Not Applicable
1 (12.5%)
Phase 2
1 (12.5%)

An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix

Completed
Conditions
Herniated Disc
Cervical Spondylosis
Degenerative Intervertebral Discs
First Posted Date
2016-06-28
Last Posted Date
2021-05-20
Lead Sponsor
DePuy Spine
Target Recruit Count
100
Registration Number
NCT02814825

CARES Lumbar Artificial Disc Registry

Terminated
Conditions
Lumbar Degenerative Disc Disease
First Posted Date
2014-05-15
Last Posted Date
2014-05-15
Lead Sponsor
DePuy Spine
Target Recruit Count
120
Registration Number
NCT02139527

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Phase 1
Completed
Conditions
Early Lumbar Disc Degeneration
Interventions
Drug: Intradiscal rhGDF-5
Drug: Vehicle control
First Posted Date
2010-08-16
Last Posted Date
2016-02-26
Lead Sponsor
DePuy Spine
Target Recruit Count
31
Registration Number
NCT01182337
Locations
🇰🇷

Yeungnam University Medical Center, Daegu, Korea, Republic of

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

🇰🇷

Gangnam Severance Hospital, Seoul, Korea, Republic of

and more 4 locations

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Phase 1
Completed
Conditions
Early Lumbar Disc Degeneration
Interventions
Drug: Intradiscal rhGDF-5
First Posted Date
2010-07-08
Last Posted Date
2016-02-26
Lead Sponsor
DePuy Spine
Target Recruit Count
40
Registration Number
NCT01158924
Locations
🇦🇺

Hunter Clinical Research, Broadmeadow, New South Wales, Australia

🇦🇺

St. George Private Hospital, Kogarah, New South Wales, Australia

🇦🇺

BrizBain & Spine, The Wesley Hospital, Auchenflower, Queensland, Australia

A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Degeneration

Phase 2
Completed
Conditions
Degenerative Disc Disease
Interventions
Drug: Intradiscal rhGDF-5
Other: Water for injection
First Posted Date
2010-05-14
Last Posted Date
2016-02-24
Lead Sponsor
DePuy Spine
Target Recruit Count
24
Registration Number
NCT01124006
Locations
🇺🇸

Hope Research Institute, Phoenix, Arizona, United States

🇺🇸

The Spine Institute, Santa Monica, California, United States

🇺🇸

Durango Orthopedic Associates/Spine Colorado, Durango, Colorado, United States

and more 7 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.